Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TTC21B antisense RNA 1 (TTC21B-AS1) is a human long non-coding RNA (lncRNA) gene located on chromosome 2, on the positive strand, in close proximity to the protein-coding gene TTC21B[1][3][7]. As an antisense RNA, it is thought to potentially regulate the expression of its sense counterpart (TTC21B), but its biological function remains largely uncharacterized[5]. TTC21B-AS1 is referenced in several genetic disease databases as being genetically associated with nephronophthisis 12 and short-rib thoracic dysplasia 4, both ciliopathies, but mechanistic or causal roles are not established[4][7]. There are no known drugs or small molecules directly targeting this lncRNA, and it is not currently considered a therapeutic target. Accordingly, TTC21B-AS1 is primarily classified as a long non-coding antisense RNA with currently limited functional annotation.
Not applicable (no known targeted drugs or interventions)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TTC21B antisense RNA 1 (TTC21B-AS1).